Skip to content

SAB BIOTHERAPEUTICS, INC.: 10-Q filed 2023-08-21

What SAB BIOTHERAPEUTICS, INC. reported in its quarterly report filed 2023-08-21 (fiscal Q2 2023): 39 published measures, 113 facts as tagged in accession 0001437749-23-024224.

This filing

Form
10-Q (quarterly report)
Filed
2023-08-21
Fiscal period
fiscal Q2 2023
Accession
0001437749-23-024224 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SAB BIOTHERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-06-3035,442,560USD
At 2022-12-3150,904,927USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-06-3015,726,109USD
At 2022-12-3119,846,785USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-06-3019,716,451USD
At 2023-03-3124,402,522USD
At 2022-12-3131,058,142USD
At 2022-06-3037,121,272USD
At 2022-03-3141,258,266USD
At 2021-12-3138,549,913USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-06-307,774,459USD
At 2022-12-3115,046,894USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-6,880,886USD91
2023-01-01 to 2023-06-30-14,234,706USD181
2023-01-01 to 2023-03-31-7,353,820USD90
2022-04-01 to 2022-06-30-4,775,996USD91
2022-01-01 to 2022-06-30-3,790,132USD181
2022-01-01 to 2022-03-31985,863USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-6,504,873USD181
2022-01-01 to 2022-06-30-13,985,767USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-06-3043,984USD181
2022-01-01 to 2022-06-301,970,156USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-04-01 to 2023-06-3085,518USD91
2023-01-01 to 2023-06-30666,619USD181
2022-04-01 to 2022-06-306,350,525USD91
2022-01-01 to 2022-06-3018,153,601USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2023-04-01 to 2023-06-3085,518USD91
2023-01-01 to 2023-06-30666,619USD181
2022-04-01 to 2022-06-306,350,525USD91
2022-01-01 to 2022-06-3018,153,601USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-723,578USD181
2022-01-01 to 2022-06-30-7,048,992USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-43,984USD181
2022-01-01 to 2022-06-30-1,893,766USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-06-30-62,104,461USD
At 2022-12-31-47,869,755USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-04-01 to 2023-06-3050,421,262shares91
2023-01-01 to 2023-06-3050,407,412shares181
2022-04-01 to 2022-06-3042,999,413shares91
2022-01-01 to 2022-06-3043,048,254shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-0.14USD/shares91
2023-01-01 to 2023-06-30-0.28USD/shares181
2022-04-01 to 2022-06-30-0.11USD/shares91
2022-01-01 to 2022-06-30-0.09USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-04-01 to 2023-06-300USD91
2023-01-01 to 2023-06-300USD181
2022-04-01 to 2022-06-30-92,281USD91
2022-01-01 to 2022-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-06-3021,527,612USD
At 2022-12-3123,250,853USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-06-301,247,595USD181
2022-01-01 to 2022-06-301,467,461USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-6,476,618USD91
2023-01-01 to 2023-06-30-13,878,627USD181
2022-04-01 to 2022-06-30-6,542,944USD91
2022-01-01 to 2022-06-30-13,250,282USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-06-309,006,180USD
At 2022-12-3122,097,453USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-04-01 to 2023-06-3075,320USD91
2023-01-01 to 2023-06-30167,705USD181
2022-04-01 to 2022-06-3071,237USD91
2022-01-01 to 2022-06-30143,259USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-06-3011,011,035USD
At 2022-12-3114,993,344USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-06-301,403,847USD
At 2022-12-313,679,116USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-06-30364,117USD
At 2022-12-315,556,577USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-04-01 to 2023-06-306,562,136USD91
2023-01-01 to 2023-06-3014,545,246USD181
2022-04-01 to 2022-06-3012,893,469USD91
2022-01-01 to 2022-06-3031,403,883USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-04-01 to 2023-06-303,662,130USD91
2023-01-01 to 2023-06-308,197,851USD181
2022-04-01 to 2022-06-308,584,427USD91
2022-01-01 to 2022-06-3021,947,692USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-06-3052,314,656shares
At 2022-12-3150,394,262shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-06-3087,336,872USD
At 2022-12-3184,444,049USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-06-30730,583USD
At 2022-12-311,192,054USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2023-06-30637,780USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2023-06-3029,614,665USD
At 2022-12-3129,529,375USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-06-308,087,053USD
At 2022-12-316,278,522USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-6,880,886USD91
2023-01-01 to 2023-06-30-14,234,706USD181
2022-04-01 to 2022-06-30-4,868,277USD91
2022-01-01 to 2022-06-30-3,790,132USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-302,900,006USD91
2023-01-01 to 2023-06-306,347,395USD181
2022-04-01 to 2022-06-304,309,042USD91
2022-01-01 to 2022-06-309,456,191USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2023-04-01 to 2023-06-30870,000USD91
2023-01-01 to 2023-06-301,767,226USD181
2022-04-01 to 2022-06-30750,000USD91
2022-01-01 to 2022-06-301,385,427USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-404,268USD91
2023-01-01 to 2023-06-30-356,079USD181
2022-04-01 to 2022-06-301,674,667USD91
2022-01-01 to 2022-06-309,460,150USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-06-30120,022USD181
2022-01-01 to 2022-06-30143,259USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2023-04-01 to 2023-06-30118,000USD91
2023-01-01 to 2023-06-30236,000USD181
2022-04-01 to 2022-06-30309,000USD91
2022-01-01 to 2022-06-30621,000USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-5,194,842USD181
2022-01-01 to 2022-06-301,601,964USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-2,275,271USD181
2022-01-01 to 2022-06-30485,058USD181

Inspect the source

Entity
SAB BIOTHERAPEUTICS, INC. / CIK 0001833214
Captured
2026-09-21T17:30:30.932Z
SEC response SHA-256
77a9d5e74034d5680bee440489a5722f0205b7102ec23dd33e3ff98bbc2065ac

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001833214.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))